Back to Search
Start Over
Upregulation of circ‐FBL promotes myogenic proliferation in myasthenia gravis by regulation of miR‐133/PAX7
- Source :
- Cell Biology International. 45:2287-2293
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Myasthenia gravis (MG) is a disease involving neuromuscular transmission that causes fatigue of skeletal muscles and fluctuating weakness. It has been shown that impairment of myogenic differentiation and myofiber maturation may be the underlying cause of MG. In this study, we detected the abnormal expression of circular RNA (circRNA) using next-generation sequencing in patients with MG. We then investigated the regulatory mechanism and the relationship among circRNA, microRNA, and messenger RNA using quantitative reverse-transcription polymerase chain reaction, bioinformatics analysis, and luciferase report analysis. The expression of inflammatory cytokines and regulatory T lymphocytes was shown to be increased. Circ-FBL was significantly increased in MG patients. Bioinformatics and luciferase report analyses confirmed that miR-133 and PAX7 were the downstream targets of circ-FBL. Overexpression of circ-FBL promoted myoblast proliferation by regulation of miR-133/PAX7. Taken together, our study showed that upregulation of circ-FBL promoted myogenic proliferation in patients with MG by regulating miR-133/PAX7.
- Subjects :
- Myoblast proliferation
Neuromuscular transmission
Apoptosis
Biology
Muscle Development
Proinflammatory cytokine
Mice
Downregulation and upregulation
Cell Movement
Circular RNA
Cell Line, Tumor
Myasthenia Gravis
microRNA
medicine
Animals
Humans
RNA, Messenger
Cell Proliferation
Messenger RNA
PAX7 Transcription Factor
Cell Differentiation
RNA, Circular
Cell Biology
General Medicine
medicine.disease
Myasthenia gravis
Mice, Inbred C57BL
MicroRNAs
Cancer research
Subjects
Details
- ISSN :
- 10958355 and 10656995
- Volume :
- 45
- Database :
- OpenAIRE
- Journal :
- Cell Biology International
- Accession number :
- edsair.doi.dedup.....4f055415ae5df6857be4d60d8b8782df